The pharmaceutical industry’s greatest value lies in the quality of life that its drugs provide – plus the innovative programs that help support adherence and education.
Walgreens Boots Alliance Inc. shares fell 12 percent after the company cut the drug retailer’s 2019 earnings growth forecast and reported lower-than-expected quarterly profit in the face of stubbornly low generic drug prices in a crowded market.
Merix Pharmaceutical Corp. announced the company’s proprietary botanical extract formula VIRACEA was found to be highly active against HSV-1 and HSV-2 in laboratory testing.
As drug prices fall under increased scrutiny, payers and regulators are targeting some key initiatives that could change the dynamic of pharmacy benefit management over the next 12 months. These emerging trends point to potentially rougher terrain for drugmakers looking to increase market share as payers take a more active role in enforcing formularies.
CVS Health and Cleveland Clinic expanded their eight-year clinical affiliation to enhance access to care for patients throughout Northeast Ohio and Florida, and improve quality, coordinated delivery of care, and health outcomes for patients.
